Clinical Trials Directory

Trials / Unknown

UnknownNCT04303767

The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine

The Reparative Effect of Casein Phosphopeptide Amorphous Calcium Phosphate Varnish on Caries Affected Dentine in Primary Teeth (Randomized Controlled Clinical Trial)

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
132 (estimated)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
6 Years – 11 Years
Healthy volunteers
Accepted

Summary

Teeth selected for intervention with Atraumatic Restorative Treatment will receive Glass Ionomer restorations (control) or MI varnish (test) before receiving the Glass Ionomer restoration

Detailed description

Patients selected to participate in the study will be randomly assigned into 2 groups. Group 1 (test): who will receive casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP) + ART in the teeth selected, excavating only the caries infected dentine and preserving the caries affected dentine. Group 2 (control): Who will receive ART only in the teeth selected, excavating only the caries infected dentine and preserving the caries affected dentine.

Conditions

Interventions

TypeNameDescription
DRUGCasein phosphopeptide amorphous calcium phosphatevarnish containing calcium and phospate ions which act as a source for tooth remineralization
PROCEDUREAtraumatic restorative treatmentexcavation of dental caries and restoring with light cured Glass Ionomer Restoration

Timeline

Start date
2020-03-01
Primary completion
2020-08-01
Completion
2021-02-01
First posted
2020-03-11
Last updated
2020-03-11

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04303767. Inclusion in this directory is not an endorsement.